| 8/27/2019 | HY | Market Commentary: Pharma names see negativity; Range Resources varies; GTT declines
|
| 8/26/2019 | HY | Market Commentary: Endo higher in pharma space; SRC Energy jumps on acquisition news; Dish better
|
| 8/26/2019 | HY | Market Commentary: Endo, Mallinckrodt notes better on settlement news; DISH rises after analyst upgrade
|
| 8/23/2019 | HY | Market Commentary: Oil names negative; Sinclair, L Brands mixed; $10.4 billion of inflows; indexes better
|
| 8/21/2019 | HY | Market Commentary: Elanco varies after animal health buyout news; oil names trend positive; PG&E rises
|
| 8/20/2019 | HY | Market Commentary: PG&E continues to decline; Endo gains after settling suit; Tenet varies
|
| 7/1/2019 | HY | Market Commentary: CSC Holdings prices; Western Digital gains; Endo drops; Coty down on restructuring
|
| 3/26/2019 | HY | Market Commentary: Allison Transmission oversubscribed; Endo, Par Pharma jump; Bed Bath & Beyond surges
|
| 3/15/2019 | HY | Market Commentary: Power Solutions carries over; SS&C Technologies, Par in focus; Community Health drops
|
| 3/15/2019 | HY | Market Commentary: Morning Commentary: Power Solutions megadeal eyed; new Par Pharma notes post gains
|
| 3/14/2019 | HY | Market Commentary: SS&C Technologies, Endo price; Amkor, Ashton Woods trade up; funds add $1.04 billion
|
| 3/14/2019 | HY | New Issue: Endo/Par Pharmaceutical sells upsized $1.5 billion eight-year notes at par to yield 7˝%
|
| 3/14/2019 | BKDDHY | Moody’s cuts Endo debt, rates revolver, notes Ba3
|
| 3/14/2019 | BKDDHY | S&P trims Endo International, rates Par Pharma notes B+
|
| 3/14/2019 | HY | Endo/Par Pharmaceutical to sell $1 billion eight-year notes Thursday
|
| 9/21/2015 | HYLM | Par Pharmaceutical plans to redeem 7 3/8% notes due 2020 on Sept. 30
|
| 5/20/2015 | BKHY | S&P puts Par Pharmaceuticals on positive watch
|
| 5/18/2015 | CLHY | Market Commentary: WideOpenWest, Aria Energy break; Par Pharmaceutical loans slide with acquisition by Endo
|
| 5/18/2015 | BKHY | Moody’s could lift Par Pharma
|
| 2/19/2015 | CLHY | Market Commentary: PetSmart, Par Pharmaceutical break; Waste Industries, Veresen, BATS, Healogics tweak deals
|
| 2/10/2015 | CLHY | Market Commentary: AssuredPartners breaks; Panda Temple, Par Pharmaceutical release talk; Healogics floats OID
|
| 2/10/2015 | BKDDHY | Moody's changes Par to stable, rates add-on B1
|
| 2/9/2015 | CLHY | Market Commentary: Citgo Holding, Phoenix Services hit secondary; PetSmart reveals pricing guidance with launch
|
| 2/9/2015 | BKHY | S&P rates Par Pharma loan B
|
| 2/3/2014 | BKDDHY | S&P cuts Par Pharmaceutical
|
| 1/22/2014 | BKHY | S&P: Par Pharmaceutical on negative watch
|
| 1/31/2013 | BKHY | S&P rates Par loan B+
|
| 10/19/2012 | BKHY | S&P: Par Pharmaceuticals loan B+, notes B-
|
| 9/19/2012 | HY | Market Commentary: Nationstar, AOT deals price, move up, Hovnanian, Intelsat also drive by; calendar swells
|
| 9/18/2012 | BKHY | S&P: Par Pharmaceutical unchanged
|
| 9/18/2012 | HY | New Issue: Par Pharma prices $490 million eight-year notes at par to yield 7 3/8%
|
| 9/18/2012 | HY | Market Commentary: PDVSA bonds active, soft; FMG's new loan helps bonds, stock; Patriot Coal dips; ResCap rises
|
| 9/17/2012 | HY | Par Pharma talks $490 million eight-year notes with 71/2% area yield
|
| 9/17/2012 | HY | Market Commentary: High-yield market muted due to holiday; Navistar downgraded, bonds little changed; Sprint firms
|
| 9/11/2012 | HY | Market Commentary: D.R. Horton, Hiland price; Horton yields early gains; new NRG up; overall market firmer
|
| 9/11/2012 | HY | Par Pharma provides details on $490 million eight-year notes offering
|
| 9/7/2012 | HY | Par Pharmaceutical expected to kick off $490 million notes on Thursday
|
| 9/7/2012 | HY | Market Commentary: Tesoro, Hub price to cap over $5 billion week; new deals mostly up by 2 points
|
| 9/6/2012 | BKHY | S&P rates Par Pharmaceuticals loan B+, notes B-
|
| 8/22/2012 | HY | Market Commentary: Primary quiet, though Par Pharmaceuticals seen planning deal; VWR firm again, ATP still busy
|
| 8/22/2012 | HY | Par Pharma expected to bring $490 million notes by mid-September
|
| 8/2/2012 | BKHY | Par Pharma plans $1.13 billion loan, $490 million bridge for buyout
|
